{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:40:17Z","timestamp":1780105217161,"version":"3.54.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology (IN)","doi-asserted-by":"publisher","award":["SB\/FT\/LS-310\/2012"],"award-info":[{"award-number":["SB\/FT\/LS-310\/2012"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research (IN)","doi-asserted-by":"publisher","award":["CSIR NWP BSC0114"],"award-info":[{"award-number":["CSIR NWP BSC0114"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00109-016-1384-5","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T01:37:46Z","timestamp":1454290666000},"page":"695-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis"],"prefix":"10.1007","volume":"94","author":[{"given":"Preeti","family":"Vishwakarma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Chandrakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanta","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"key":"1384_CR1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","volume":"354","author":"BL Herwaldt","year":"1999","unstructured":"Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191\u20131199","journal-title":"Lancet"},{"key":"1384_CR2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","volume":"17","author":"SL Croft","year":"2011","unstructured":"Croft SL, Olliaro P (2011) Leishmaniasis chemotherapy\u2014challenges and opportunities. Clin Microbiol Infect 17:1478\u20131483","journal-title":"Clin Microbiol Infect"},{"key":"1384_CR3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/trstmh\/tru199","volume":"109","author":"GD Shanks","year":"2015","unstructured":"Shanks GD, Edstein MD, Jacobus D (2015) Evolution from double to triple-antimalarial drug combinations. Trans R Soc Trop Med Hyg 109:182\u2013188","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1384_CR4","first-page":"398","volume":"120","author":"MS Jawahar","year":"2004","unstructured":"Jawahar MS (2004) Current trends in chemotherapy of tuberculosis. Indian J Med Res 120:398\u2013417","journal-title":"Indian J Med Res"},{"key":"1384_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/1042819031000060537","volume":"44","author":"A Klepfish","year":"2003","unstructured":"Klepfish A, Schattner A, Shvidel L, Shtalrid M, Haran M, Bentwich Z, Berrebi A (2003) Successful treatment of aggressive HIV-associated non-Hodgkin\u2019s lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic option. Leuk Lymphoma 44:349\u2013351","journal-title":"Leuk Lymphoma"},{"key":"1384_CR6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-3156.2009.02306.x","volume":"14","author":"P Olliaro","year":"2009","unstructured":"Olliaro P, Darley S, Laxminarayan R, Sundar S (2009) Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India. Trop Med Int Health 14:918\u2013925","journal-title":"Trop Med Int Health"},{"key":"1384_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jac\/dkr409","volume":"67","author":"RF Rodrigues","year":"2012","unstructured":"Rodrigues RF, Charret KS, Campos MC, Amaral V, Echevarria A, Reis CD, Canto-Cavalheiro MM, Leon LL (2012) The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis. J Antimicrob Chemother 67:182\u2013190","journal-title":"J Antimicrob Chemother"},{"key":"1384_CR8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.129.4.1627","volume":"129","author":"RA Lewis","year":"1982","unstructured":"Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ (1982) Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129:1627\u20131631","journal-title":"J Immunol"},{"key":"1384_CR9","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1074\/jbc.M110314200","volume":"277","author":"T Shibata","year":"2002","unstructured":"Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, Uchida K (2002) 15-Deoxy- 12,14-prostaglandin J2: a prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 277:10459\u201310466","journal-title":"J Biol Chem"},{"key":"1384_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/bj2620195","volume":"262","author":"J Kuiper","year":"1989","unstructured":"Kuiper J, Zijlstra FJ, Kamps JA, Van Berkel TJ (1989) Cellular communication inside the liver. Binding, conversion and metabolic effect of prostaglandin D2 on parenchymal liver cells. Biochem J 262:195\u2013201","journal-title":"Biochem J"},{"key":"1384_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0003-9861(88)90477-8","volume":"260","author":"M Ujihara","year":"1988","unstructured":"Ujihara M, Urade Y, Eguchi N, Hayashi H, Ikai K, Hayaishi O (1988) Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. Arch Biochem Biophys 260:521\u2013531","journal-title":"Arch Biochem Biophys"},{"key":"1384_CR12","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1523\/JNEUROSCI.0321-07.2007","volume":"27","author":"H Taniguchi","year":"2007","unstructured":"Taniguchi H, Mohri I, Okabe-Arahori H, Aritake K, Wada K, Kanekiyo T, Narumiya S, Nakayama M, Ozono K, Urade Y (2007) Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. J Neurosci 27:4303\u20134312","journal-title":"J Neurosci"},{"key":"1384_CR13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0005-2760(98)00163-5","volume":"1436","author":"Y Urade","year":"1999","unstructured":"Urade Y, Hayaishi O (1999) Prostaglandin D2 and sleep regulation. Biochim Biophys Acta 1436:606\u2013615","journal-title":"Biochim Biophys Acta"},{"key":"1384_CR14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI109497","volume":"64","author":"B Cooper","year":"1979","unstructured":"Cooper B, Ahern D (1979) Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders. J Clin Invest 64:586\u2013590","journal-title":"J Clin Invest"},{"key":"1384_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","volume":"38","author":"JD Morrow","year":"1989","unstructured":"Morrow JD, Parsons WG, Roberts LJ (1989) Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins 38:263\u2013274","journal-title":"Prostaglandins"},{"key":"1384_CR16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","volume":"53","author":"J Berger","year":"2002","unstructured":"Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409\u2013435","journal-title":"Annu Rev Med"},{"key":"1384_CR17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.biochem.70.1.341","volume":"70","author":"TM Willson","year":"2001","unstructured":"Willson TM, Lambert MH, Kliewer SA (2001) Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem 70:341\u2013367","journal-title":"Annu Rev Biochem"},{"key":"1384_CR18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/cdd.2010.128","volume":"18","author":"L Lalier","year":"2011","unstructured":"Lalier L, Cartron P-F, Olivier C, Log\u00e9 C, Bougras G, Robert J-M, Oliver L, Vallette FM (2011) Prostaglandins antagonistically control Bax activation during apoptosis. Cell Death Differ 18:528\u2013537","journal-title":"Cell Death Differ"},{"key":"1384_CR19","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/sj.cdd.4401862","volume":"13","author":"K Figarella","year":"2006","unstructured":"Figarella K, Uzcategui NL, Beck A, Schoenfeld C, Kubata BK, Lang F, Duszenko M (2006) Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress. Cell Death Differ 13:1802\u20131814","journal-title":"Cell Death Differ"},{"key":"1384_CR20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbamcr.2004.10.016","volume":"1743","author":"Y-C Chen","year":"2005","unstructured":"Chen Y-C, Shen S-C, Tsai S-H (2005) Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochim Biophys Acta 1743:291\u2013304","journal-title":"Biochim Biophys Acta"},{"key":"1384_CR21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.bbrc.2004.02.151","volume":"316","author":"K Tanaka","year":"2004","unstructured":"Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K (2004) Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 316:1009\u20131014","journal-title":"Biochem Biophys Res Commun"},{"key":"1384_CR22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/eji.200323330","volume":"33","author":"C Faveeuw","year":"2003","unstructured":"Faveeuw C, Gosset P, Bureau F, Angeli V, Hirai H, Maruyama T, Narumiya S, Capron M, Trottein F (2003) Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur J Immunol 33:889\u2013898","journal-title":"Eur J Immunol"},{"key":"1384_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","volume":"133","author":"Hamidullah","year":"2012","unstructured":"Hamidullah, Changkija B, Konwar R (2012) Role of interleukin-10 in breast cancer. Breast Cancer Res Treat 133:11\u201321","journal-title":"Breast Cancer Res Treat"},{"key":"1384_CR24","doi-asserted-by":"crossref","first-page":"29681","DOI":"10.1074\/jbc.M201517200","volume":"277","author":"AM Lennon","year":"2002","unstructured":"Lennon AM, Ramaug\u00e9 M, Dessouroux A, Pierre M (2002) MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-delta(12\u201314)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. J Biol Chem 277:29681\u201329685","journal-title":"J Biol Chem"},{"key":"1384_CR25","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1096\/fj.08-124982","volume":"23","author":"P Kalantari","year":"2009","unstructured":"Kalantari P, Narayan V, Henderson AJ, Prabhu KS (2009) 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification. FASEB J 23:2366\u20132373","journal-title":"FASEB J"},{"key":"1384_CR26","doi-asserted-by":"crossref","first-page":"e94596","DOI":"10.1371\/journal.pone.0094596","volume":"9","author":"R Shivahare","year":"2014","unstructured":"Shivahare R, Vishwakarma P, Parmar N, Yadav PK, Kar S (2014) Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis. PLoS ONE 9:e94596","journal-title":"PLoS ONE"},{"key":"1384_CR27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10495-008-0224-7","volume":"13","author":"HK Majumder","year":"2008","unstructured":"Majumder HK, Nac ROS\u00c1, Calcium \u00c1 (2008) Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani. Apoptosis 13:867\u2013882","journal-title":"Apoptosis"},{"key":"1384_CR28","unstructured":"Stauber LA (1958) Host resistance to the khartum strain of Leishmania donovani. Rice Inst. Pam."},{"key":"1384_CR29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jac\/dkq502","volume":"66","author":"S Kar","year":"2011","unstructured":"Kar S, Sharma G, Das PK (2011) Fucoidan cures infection with both antimony-susceptible and -resistant strains of Leishmania donovani through Th1 response and macrophage-derived oxidants. J Antimicrob Chemother 66:618\u2013625","journal-title":"J Antimicrob Chemother"},{"key":"1384_CR30","doi-asserted-by":"crossref","first-page":"e14666","DOI":"10.1371\/journal.pone.0014666","volume":"6","author":"F Fonseca-Silva","year":"2011","unstructured":"Fonseca-Silva F, Inacio JDF, Canto-Cavalheiro MM, Almeida-Amaral EE (2011) Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis. PLoS ONE 6:e14666","journal-title":"PLoS ONE"},{"key":"1384_CR31","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","volume":"48","author":"QL Fivelman","year":"2004","unstructured":"Fivelman QL, Adagu IS, Warhurst DC (2004) Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother 48:4097\u20134102","journal-title":"Antimicrob Agents Chemother"},{"key":"1384_CR32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","volume":"41","author":"MC Berenbaum","year":"1989","unstructured":"Berenbaum MC (1989) What is synergy? Pharmacol Rev 41:93\u2013141","journal-title":"Pharmacol Rev"},{"key":"1384_CR33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/AAC.00700-11","volume":"56","author":"P Palit","year":"2012","unstructured":"Palit P, Hazra A, Maity A, Vijayan RSK, Manoharan P, Banerjee S, Mondal NB, Ghoshal N, Ali N (2012) Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis. Antimicrob Agents Chemother 56:432\u2013445","journal-title":"Antimicrob Agents Chemother"},{"key":"1384_CR34","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1365-2958.2006.05459.x","volume":"62","author":"MM Kulkarni","year":"2006","unstructured":"Kulkarni MM, McMaster WR, Kamysz E, Kamysz W, Engman DM, McGwire BS (2006) The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Mol Microbiol 62:1484\u20131497","journal-title":"Mol Microbiol"},{"key":"1384_CR35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","volume":"10","author":"J Griensven van","year":"2010","unstructured":"van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M (2010) Combination therapy for visceral leishmaniasis. Lancet Infect Dis 10:184\u2013194","journal-title":"Lancet Infect Dis"},{"key":"1384_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1","journal-title":"J Antimicrob Chemother"},{"key":"1384_CR37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/AAC.44.1.200-204.2000","volume":"44","author":"F Pica","year":"2000","unstructured":"Pica F, Palamara AT, Rossi A, Marco AD, Amici C, Santoro MG (2000) Delta 12-prostaglandin J2 is a potent inhibitor of influenza a virus replication. Antimicrob Agents Chemother 44:200\u2013204","journal-title":"Antimicrob Agents Chemother"},{"key":"1384_CR38","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1158\/1078-0432.CCR-08-3101","volume":"15","author":"S-W Shin","year":"2009","unstructured":"Shin S-W, Seo C-Y, Han H, Han J-Y, Jeong J-S, Kwak J-Y, Park J-I (2009) 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res 15:5414\u20135425","journal-title":"Clin Cancer Res"},{"key":"1384_CR39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/med.1006","volume":"21","author":"DS Straus","year":"2001","unstructured":"Straus DS, Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21:185\u2013210","journal-title":"Med Res Rev"},{"key":"1384_CR40","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1471-4159.2006.04183.x","volume":"99","author":"NK Phulwani","year":"2008","unstructured":"Phulwani NK, Douglas LF, Vitaliy G, Candan A, Kielian T (2008) 15-deoxy-\u039412,14 -prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-\u03b3-independent pathway. J Neurochem 99:1389\u20131402","journal-title":"J Neurochem"},{"key":"1384_CR41","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","volume":"166","author":"PC Melby","year":"2001","unstructured":"Melby PC, Chandrasekar B, Zhao W, Coe JE (2001) The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol 166:1912\u20131920","journal-title":"J Immunol"},{"key":"1384_CR42","first-page":"27","volume":"133","author":"S Gupta","year":"2011","unstructured":"Gupta S, Nishi (2011) Visceral leishmaniasis: experimental models for drug discovery. Indian J Med Res 133:27\u201339","journal-title":"Indian J Med Res"},{"key":"1384_CR43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","volume":"28","author":"S Nyl\u00e9n","year":"2007","unstructured":"Nyl\u00e9n S, Sacks D (2007) Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28:378\u2013384","journal-title":"Trends Immunol"},{"key":"1384_CR44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495\u2013516","journal-title":"Toxicol Pathol"},{"key":"1384_CR45","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1016\/S0021-9258(17)44287-6","volume":"258","author":"FA Fitzpatrickz","year":"1983","unstructured":"Fitzpatrickz FA, Wynalda MA (1983) Albumin-catalyzed metabolism of prostaglandin D2. J Biol Chem 258:11713\u201311718","journal-title":"J Biol Chem"},{"key":"1384_CR46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","volume":"193","author":"H Hirai","year":"2001","unstructured":"Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor Crth2. J Exp Med 193:255\u2013262","journal-title":"J Exp Med"},{"key":"1384_CR47","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.4049\/jimmunol.175.10.6531","volume":"175","author":"L Xue","year":"2005","unstructured":"Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, Pettipher R (2005) Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 175:6531\u20136536","journal-title":"J Immunol"},{"key":"1384_CR48","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jac\/dkq542","volume":"66","author":"K Seifert","year":"2011","unstructured":"Seifert K, Munday J, Syeda T, Croft SL (2011) In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani. J Antimicrob Chemother 66:850\u2013854","journal-title":"J Antimicrob Chemother"},{"key":"1384_CR49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","volume":"50","author":"K Seifert","year":"2006","unstructured":"Seifert K, Croft SL (2006) In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrob Agents Chemother 50:73\u201379","journal-title":"Antimicrob Agents Chemother"},{"key":"1384_CR50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jac\/dkt318","volume":"69","author":"TE Morais de","year":"2014","unstructured":"de Morais TE, Gallupo MK, Rodrigues LF, Romanha AJ, Rabello A (2014) In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species. J Antimicrob Chemother 69:150\u2013154","journal-title":"J Antimicrob Chemother"},{"key":"1384_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/jm00054a008","volume":"36","author":"B Resul","year":"1993","unstructured":"Resul B, Stjernschantz J, No K, Liljebris C, Sel\u00e9n G, Astin M, Karlsson M, Bito LZ (1993) Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents. J Med Chem 36:243\u2013248","journal-title":"J Med Chem"},{"key":"1384_CR52","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1021\/cr068365a","volume":"107","author":"S Das","year":"2007","unstructured":"Das S, Chandrasekhar S, Yadav JS, Gr\u00e9e R (2007) Recent developments in the synthesis of prostaglandins and analogues. Chem Rev 107:3286\u20133337","journal-title":"Chem Rev"},{"key":"1384_CR53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature11411","volume":"489","author":"G Coulthard","year":"2012","unstructured":"Coulthard G, Erb W, Aggarwal VK (2012) Stereocontrolled organocatalytic synthesis of prostaglandin PGF2\u03b1 in seven steps. Nature 489:278\u2013281","journal-title":"Nature"},{"key":"1384_CR54","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1021\/acs.orglett.5b02181","volume":"17","author":"J Egger","year":"2015","unstructured":"Egger J, Fischer S, Bretscher P, Freigang S, Kopf M, Carreira EM (2015) Total synthesis of prostaglandin 15d-PGJ(2) and investigation of its effect on the secretion of IL-6 and IL-12. Org Lett 17:4340\u20134343","journal-title":"Org Lett"},{"key":"1384_CR55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/ol035590v","volume":"6","author":"KM Brummond","year":"2004","unstructured":"Brummond KM, Sill PC, Chen H (2004) The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry. Org Lett 6:149\u2013152","journal-title":"Org Lett"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-016-1384-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1384-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T08:13:57Z","timestamp":1748765637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-016-1384-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1007\/s00109-016-1384-5","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]}}}